v3.25.3
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net loss from continuing operations $ (23,977) $ (31,317)
Adjustments to reconcile net loss to net cash provided by operating activities    
Accretion expense and accrued interest 6,128 8,448
Depreciation of property and equipment and amortization of intangible assets 11,663 11,357
Amortization of operating right-of-use assets 1,208 1,163
Share-based compensation 3,659 7,720
Deferred income tax expense (benefit) 291 (986)
Loss (gain) on fair value of derivative liabilities 347 (2,608)
Unrealized and realized loss on investments 736 213
(Gain) loss from revaluation of contingent consideration (825) 3,547
Provision for expected credit loss (recovery) 988 (1,136)
Loss on extinguishment of debt 1,432 2,096
Unrealized and realized foreign exchange (gain) loss (530) 175
Impairment and other (5) 1,270
Changes in operating assets and liabilities    
Receivables 2,084 671
Inventory 6,056 1,005
Accounts payable and accrued liabilities (5,336) (3,187)
Income taxes payable and tax related liabilities 22,027 42,998
Prepaid expense and other current assets 49 (1,129)
Other assets and liabilities (396) (876)
Net cash provided by operating activities - continuing operations 25,599 39,424
Net cash used in operating activities - discontinued operations (12,085) (11,222)
Net cash provided by operating activities 13,514 28,202
Investing activities    
Investment in property and equipment (6,898) (4,111)
Investment in note receivable, net of interest received 165 (1,523)
Investment in intangible assets (726) (115)
Cash portion of consideration paid in acquisitions, net of cash acquired (5,128) (250)
Net cash used in investing activities - continuing operations (12,587) (5,999)
Net cash used in investing activities - discontinued operations (877) (270)
Net cash used in investing activities (13,464) (6,269)
Financing activities    
Proceeds from loan payable, net of transaction costs 78,944 129,382
Loan principal paid (65,898) (136,290)
Capital distributions paid to non-controlling interests (2,046) (4,433)
Payment for contingent consideration (386)  
Payments made for financing obligations and finance lease   (271)
Loan exit fee paid (233) (500)
Repurchases of common shares (377) (138)
Net cash provided by (used in) financing activities- continuing operations 10,004 (12,250)
Net cash used in financing activities- discontinued operations   (8,066)
Net cash provided by (used in) financing activities 10,004 (20,316)
Net increase in cash and cash equivalents and restricted cash during the period 10,054 1,617
Net effects of foreign exchange (415) 278
Cash and cash equivalents and restricted cash, beginning of the period 26,987 25,347
Cash and cash equivalents and restricted cash, end of the period 36,626 27,242
Supplemental disclosure with respect to cash flows    
Cash paid (received) for income tax, net 9,623 (8,449)
Interest paid 20,627 17,877
Non-cash transactions    
Equity issued for acquisitions 1,278 4,674
Equity issued for price protection on contingent consideration 1,904 693
Change in accrued capital expenditures $ 1,321 $ 131

Source

10-Q PDF
XBRL